Rare diseases
Investigational molecules
Locations
Halderstrasse 29, Innenstadt, 86150 Augsburg, Germany
Haematologie-Onkologie im Zentrum MVZ GmbH in Augsburg, Germany specialises in clinical trials of conditions such as Breast cancer, Hormone receptor positive HER2 negative breast cancer, Breast cancer female, Triple negative breast cancer, and other specialisations. This site conducts important research.
The medical center is at the forefront of breast cancer research, focusing on innovative therapies for various subtypes, including HER2-positive and hormone receptor-positive breast cancers.
Through clinical trials like ADAPT-HER2-IV and CAPItello-292, the center is pioneering personalized treatment approaches, enhancing pathologic complete response rates and improving progression-free survival.
Specializing in advanced gastrointestinal cancers, the center explores cutting-edge treatment combinations to improve patient outcomes.
The GOBLET study exemplifies the center's commitment to integrating biomarker research with clinical applications, enhancing the efficacy and safety of novel therapeutic combinations.
The center is a leader in the study of hematological malignancies, focusing on high-risk conditions such as chronic lymphocytic leukemia and polycythemia vera.
Through trials like the GAVE study and HU-F-AIM, the center is advancing the understanding of genetic risk factors and resistance mechanisms, paving the way for more effective treatments.
Clinical trials currently enrolling participants at this site.
GermanyGermanyGermanyGermanyGermanyGermanyGermanyGermanyGermanyGermanyGermanyGermanyGet verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.
See the offer for sitesTell us about your condition – we search every trial in Europe and connect you with the right site.
